XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands
3 Months Ended 6 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Dec. 30, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Net sales $ 145,417,000 $ 123,708,000 $ 293,180,000 $ 260,971,000
Cost of sales 133,654,000 114,788,000 270,555,000 241,672,000
Gross profit 11,763,000 8,920,000 22,625,000 19,299,000
Research, development and engineering expenses 1,758,000 2,287,000 3,999,000 4,583,000
Selling, general and administrative expenses 6,057,000 5,735,000 11,841,000 11,391,000
Gain on insurance proceeds, net of losses 0 (2,710,000) (431,000) (3,644,000)
Total operating expenses 7,815,000 5,312,000 15,409,000 12,330,000
Operating income 3,948,000 3,608,000 7,216,000 6,969,000
Interest expense, net 2,961,000 2,507,000 5,972,000 4,394,000
Income before income taxes 987,000 1,101,000 1,244,000 2,575,000
Income tax provision (benefit) (97,000) 134,000 (175,000) 456,000
Net income $ 1,084,000 $ 967,000 $ 1,419,000 $ 2,119,000
Net income per share - Basic (in USD per share) $ 0.10 $ 0.09 $ 0.13 $ 0.20
Weighted average shares outstanding — Basic (in shares) 10,762 10,762 10,762 10,762
Net income per share - Diluted (in USD per share) $ 0.10 $ 0.09 $ 0.13 $ 0.20
Weighted average shares outstanding — Diluted (in shares) 10,889 10,832 10,889 10,832